Pineoblastoma is a rare tumor in adults, and factors influencing survival are poorly understood. Data from the Brain Tumor Registry of Japan (BTRJ) was analyzed to examine patient, tumor, and treatment characteristics associated with increased survival in adults with pineoblastomas. All pineoblastoma cases in adults aged 16 years or older were identified in the BTRJ. Data were extracted on demographics, presentation, tumor characteristics, treatments, and outcomes. Kaplan-Meier plots, the log rank method, and p value º0.15 was used to screen variables for inclusion in a multivariate Cox regression estimating survival. In the final Cox multivariate model, all variables with p values º0.05 were considered significant predictors of survival, and all variables with p values 0.05-0.099 were considered trends. The BTRJ contained 34 adults with pineoblastomas diagnosed from 1969-1998. The patients were predominantly male (22 patients), with a median age of 35 years (range 16-66 years). Median survival from diagnosis was 25.7 months, with a median follow up of 20.5 months. Median surgical resection was 75-94%, and five of the 34 patients had gross total resection. Twenty-nine of the 34 patients received cranial irradiation therapy with a median dose of 50 Gy (range 30-70 Gy). In the final multivariate model, cranial irradiation AE40 Gy (p ＝ 0.014) and gross total resection (p ＝ 0.034) were associated with improved survival. There was a trend towards improved survival for women (p ＝ 0.099). Adult pineoblastoma patients have poor survival prognosis. Cranial irradiation therapy using at least 40 Gy and complete surgical resection are associated with improved survival.
Introduction
Pineoblastomas are rare, representing less than 0.1% of all primary brain tumors. 6, 20) Pineoblastomas usually occur in children, whereas adults account for less than 10% of cases in published series, 19) and there are no adult pineoblastoma clinical series larger than 25 patients. 4, 9) The systematic study of pineoblastomas in adults is hindered by their extreme rarity, incomplete staging, and the lack of a patient registry containing data on patient and tumor characteristics, treatments, and outcomes. In most series, treatments include chemotherapeutic and craniospinal irradiation, but the optimal regimen remains unclear.
The Brain Tumor Registry of Japan (BTRJ) is a nationwide registry of patients of all ages with primary or metastatic brain tumors. The BTRJ contains demographic, symptom, imaging, treatment, survival, functional status, and pathologic data. 6, 28) An international collaborative project between the University of Pittsburgh and the Nagoya University School of Medicine provided access to the BTRJ. We queried the BTRJ to review the largest series of adults with pineoblastomas presented to date. The BTRJ is a unique source of data as almost all brain tumors in Japan are treated and recorded by the national health care system. The most recent summary report includes a statistical analysis of 81,569 patients with primary and metastatic brain tumors who were registered from 1969 to 1993. 6) The present analysis used an expanded BTRJ dataset collected from 1969-1998. Studies of extremely rare tumors such as adult pineoblastomas can only be accomplished using large databases such as the BTRJ. 
Pineoblastoma Survival in Adults
We report the presentation, treatment, and survival of 34 adults with pineoblastoma from data deposited in the BTRJ over a 30-year interval.
Methods and Materials

I. Clinical material
We performed a retrospective analysis of the BTRJ, identifying all cases of pineoblastomas in adults 16 years of age or older at the time of original diagnosis. Brain tumors in the BTRJ are classified according to the classification of the Union International Contre Le Cancer in 1965. 38) The registry contains data on sex, date of birth, date of diagnosis, duration of symptoms prior to diagnosis, method of diagnosis (histology, cerebrospinal fluid [CSF] cytology, imaging, autopsy), surgeries (date(s), extent of tumor resection(s), extension, invasion), tumor diameter, functional status (pre-and postoperative performance state [PS]), tumor dissemination, irradiation therapy (type, dose, timing, target(s), use of a radiation sensitizer), chemotherapy (agent(s), timing of administration), date of last follow up, and death (date, cause). 6, 28) Surgical tumor resection is coded as 0% (i.e., biopsy or decompressive craniectomy), 1-49%, 50-74%, 75-94%, 95-99%, and 100%. In patients with two surgeries, the value of the more complete tumor resection was used in this analysis. Tumor size was recorded as the geometric mean of two diameters (mean ＝ square root[diameter 1 * diameter 2 ]). We calculated tumor volume from the diameter by assuming spherical morphology (volume ＝ 4/3 * P * (mean diameter/2) 3 ). Pre-and postoperative functional status were categorized on the PS scale, 6) a seven level classification similar to the Karnofsky Performance Status 22) ranging from 1 ＝``normal: no complaints; no evidence of disease'' to 7 ＝``moribund; fatal processes are rapidly progressing'' (Appendix). Irradiation therapy data included target(s) (cranial or craniospinal) and cranial dose in Gray (Gy). Chemotherapy data detailed agents and the timing of administration.
II. Statistical analysis
Medians, means, and 95% confidence intervals (CIs) were used to describe the central tendencies and dispersions of continuous variables. Median values were used to impute missing values for variables with Ã20% missing values for the regression analysis. We did not impute missing values for variables missing À20% of values, and these variables could not be used in the regression analyses. During the screening process of the regression analyses, nominal variables were recorded as a series of dichotomous indicator variables, and continuous and ordinal variables were dichotomized on median values.
Kaplan-Meier life tables were used to determine the unadjusted survival of the entire cohort. We then built a multivariate Cox proportional hazard model to determine which patient, tumor, and treatment characteristics were independently associated with improved survival. Variables were first screened in a univariate analysis using Kaplan-Meier productlimit estimation and the log-rank test for inclusion in the multivariate model -all variables from the univariate analyses with p º 0.15 were candidates for inclusion in a multivariate Cox proportional hazard model. Multivariate Cox proportional hazard modeling allows the estimation of the relative rate of death, or``hazard ratio'' (HR) associated with each variable while adjusting for the effects of other variables in the model. 7) In the final Cox multivariate model, p values º0.05 were considered significant, and p values 0.05-0.099 were considered trends. The appropriateness of the proportional hazard assumption for the final model was tested using Grambsch and Therneau's method. 18) In a secondary analysis, we used multivariate ordinal logistic regression to model the predictors of postoperative functional status. Candidate predictor variables were screened for inclusion in the multivariate model using a univariate ordinal logistic regression. All variables from the univariate regression analyses with p º 0.15 were then included in a (Table 1 ). An earlier analysis of the BTRJ identified 76 cases of pineoblastoma in patients of all ages diagnosed from 1969-1993, comprising 0.19% of all primary brain tumors (an analysis of pineoblastoma incidence based on more recent BTRJ data is underway). The cohort of 34 patients contained 22 males (64.7%), with a median age at presentation of 35 years (range 16-66 years). The most common clinical presentations were signs of elevated intracranial pressure (n ＝ 16, 47.1%), focal neurologic signs (n ＝ 9, 26.5%), and subjective neurological complaints (n ＝ 4, 11.8%). Two patients (5.9%) were asymptomatic at the time of diagnosis. The median tumor diameter was 2 cm (range 1-À8 cm), corresponding to a median volume of 4.2 cm 3 (range 0.5-382 cm 3 ). Only 30 patients had definite data documenting the presence (6 patients) or absence (24 patients) of spinal dissemination. In the remaining four patients, the presence or absence of disseminated disease could not be ascertained from the registry. The majority of patients (n ＝ 22) had no evidence of local tumor invasion noted during surgery.
Only 23 patients had the preoperative PS recorded in the database (Table 2) . Fifteen patients had PS grades of 1-2, consistent with the ability to perform normal activities. Pineoblastoma Survival in Adults II. Diagnosis and therapy Thirty-two of the 34 patients underwent at least one surgical procedure to reduce tumor burden or mass effect, or to establish a diagnosis (Fig. 1) . The dates of surgery ranged from April 1970 to January 1997.
Twenty-five of the 34 patients received cranial irradiation, with the tumor receiving a median dose of 50 Gy (range 30-70 Gy) ( Table 3) . Eleven patients received both cranial and spinal irradiation. Four of the six patients with documented disseminated disease received complete craniospinal radiation.
Ten of the 34 patients received chemotherapy, and nine of these 10 patients received multiple agents. The most common agents were VP-16 (n ＝ 5, 50%), cisplatin (n ＝ 4, 40%), and ACNU (n ＝ 3, 30%). The most popular combination therapy was VP-16 combined with cisplatin (n ＝ 3, 30%). Other agents used included vincristine (n ＝ 2, 20%), tegafur (n ＝ 1, 10%), methotrexate (n ＝ 1, 10%), or bleomycin (n ＝ 1, 10%). No patient received chemotherapy without also receiving radiation therapy. Of the 10 patients receiving chemotherapy, five received only cranial irradiation, and five received craniospinal radiation therapy.
III. Survival
At the time of the last recorded evaluation, 16 patients had died, and median follow up was 20.5 months (range 1-107.5 months). The Kaplan-Meier survival curve for the cohort demonstrates a median survival from time of presentation of 25.7 months (95% CI 16, 35.3 months) (Fig. 2) .
Kaplan-Meier univariate analysis was run on the following variables: age, sex, presentation symptoms, date of surgery, maximum tumor resection, tumor size, tumor invasion, extent of intracranial tumor spread, tumor extracranial dissemination, irradiation therapy cranial dose, radiation sensitizers, spinal irradiation, and chemotherapy. Missing data in 11 patients for preoperative PS prevented the inclusion of this variable in the Kaplan-Meier or Cox regression analyses. The Kaplan-Meier univariate analysis identified seven variables that met the criteria of p º 0.15 for consideration of inclusion in the multivariate model: sex, maximum tumor resection, irradiation therapy cranial dose, decreased level of consciousness at presentation, focal neurological signs at presentation, extension of tumor beyond the midline, and dural invasion of tumor.
In the multivariate Cox model, two variables were independently associated with improved survival: irradiation therapy cranial dose AE40 Gy (HR 3.8; 95% CI 1.3, 11.2; p ＝ 0.014) and complete surgical resection (HR undefined -no deaths in gross total resection group; Kaplan-Meier p ＝ 0.034) ( Table 4 ). In addition, there was a trend towards improved Figure 3 demonstrates the Kaplan-Meier survival plots for irradiation therapy dose AE40 Gy, gross total resection, and sex. In the final Cox model, Grambsch and Therneau's method showed that there was no significant deviation from the proportional hazards assumption (global test, p ＝ 0.996), and thus a Cox regression can legitimately be used to model survival in this population. Multivariate Cox regression modeling showed no significant independent association between survival and any of the other variables: age, presentation symptoms, date of surgery, tumor size, tumor invasion, extent of intracranial tumor spread, tumor extracranial dissemination, radiation sensitizers, spinal irradiation, or chemotherapy.
IV. PS
The registry did not specify when the postoperative PS was recorded, as PS values in the registry usually indicate the most recent available annual assessment. Twenty-three of the 34 patients had both pre-and postoperative PS grades recorded in the database. Surgery had no impact on the PS grades of eight patients; postoperative grades were improved in 10 patients, but worse in five patients ( Table 2) .
The ordinal logistic univariate regression analysis was run on the following variables: age, sex, presentation symptoms, date of surgery, maximum tumor resection, tumor size, tumor invasion, extent of intracranial tumor spread, tumor extracranial dissemination, irradiation therapy cranial dose, radiation sensitizers, spinal irradiation, and chemotherapy. The univariate ordinal logistic analysis identified three variables that met the criteria of p º 0.15 for consideration of inclusion in the multivariate model: maximum tumor resection Pineoblastoma Survival in Adults À50%, irradiation therapy cranial dose AE40 Gy, and any invasion of tumor noted at surgery. In the multivariate ordinal logistic regression model, only irradiation therapy dose AE40 Gy was independently associated with better postoperative PS (p ＝ 0.003). The analysis showed no significant independent association between postoperative functional status and the following variables: age, sex, presentation symptoms, date of surgery, tumor size, tumor invasion, extent of intracranial tumor spread, tumor extracranial dissemination, radiation sensitizers, spinal irradiation, or chemotherapy.
Discussion I. Histopathology
Pineoblastomas and pineocytomas are pineal parenchymal tumors that are distinct from germ cell tumors and glial tumors. 3, 33) A two-tiered staging system distinguishes pineoblastomas from pineocytomas. The pineocytoma is a well-circumscribed tumor that grossly compresses the surrounding tissue. The cells appear benign and look similar to mature pineal parenchymal cells in sheets or irregular lobules. Identification of pineocytomas is facilitated with the finding of Homer-Wright rosettes and the finding of larger pineocytomatous rosettes. Pineoblastomas, in contrast, are grossly invasive with poorly defined borders and frequent leptomeningeal spread. Histologically, pineoblastoma is very similar to medulloblastoma and has been described as``medulloblastoma pineales,'' emphasizing its similarity to other primitive neuroectodermal tumors. 20, 31) Pineoblastoma is highly cellular, with small poorly differentiated cells in pattern less sheets or aggregates. Mitosis are found along with Homer-Wright rosettes, Flexner-Wintersteiner rosettes, and areas of necrosis. 3, 33) More recently, Schild et al. 33) has divided pineal parenchymal tumors into four types: pineocytomas, intermediate tumors, mixed tumors, and pineoblastomas. The intermediate tumor is described as a transitional form between pineocytomas and pineoblastomas. The mixed tumor shows patterns of both pineocytomas and pineoblastomas. In addition to Schild's grading system, Fauchon et al. 13) have defined another scale emphasizing the number of mitoses and thereby correlating survival with mitotic activity. These grading scales are relatively recent descriptions, and most series of pineal parenchymal tumors have used the two-tiered grading system. 3, 20) Pineoblastomas are rare tumors that are sometimes simply described as supratentorial primitive neuroectodermal tumors (PNETs). 20, 31) Pineoblastomas and cerebellar medulloblastomas both share the presence of Homer-Wright rosettes, which are widely accepted to represent abortive attempts at neuroblastic differentiation. 20) In addition, mononucleated and multinucleated tumor giant cells are present in pineoblastomas as in cerebellar medulloblastomas. 3) Hence, the category of PNETs has been said to include both cerebellar medulloblastomas and pineoblastomas.
The BTRJ does not require a centralized review of pathologic tissue for entry into the database, so we could not verify the classification of pineal parenchymal tumors in this series. The pathologic grading scale employed in the BTRJ is derived from Zulch 38) and describes only the two-tiered grades of pineocytoma versus pineoblastoma.
II. Survival
The overall median survival in our series of adults with pineoblastomas was 25.7 months. Chang et al. 4) reported a series of 11 adults with pineoblastomas with a median survival of 30 months. Using a grading scale for pineal parenchymal tumors based on number of mitoses, Fauchon et al. 13) reported a median survival time of 38 months and 16 months for adult and pediatric patients with the higher grade tumors (grades 3 and 4), respectively. Schild et al. 33) reported a 5-year survival rate of 58% for the 21 adult and pediatric patients with mixed, intermediate, or pure pineoblastomas. If the intermediate grade tumors are removed from Schild's or Fauchon's analysis, the survival rates remain poor.
III. Extent of resection
The most striking predictor of survival in our patient population was gross total resection. No patient in whom the surgeon was able to obtain gross total resection died during follow up ranging from 21.7 to 107.5 months (Fig. 3B) . The importance of obtaining gross total resection has not been previously described for PNETs in any location or age distribution. No statistical difference between À90% resection versus º90% resection was found in children with pineoblastomas. 21) In children with cerebral PNETs, there was no correlation between extent of resection and survival in those children treated with radiation therapy. 35) However, gross total resection was associated with better local control. 35) Similarly, an adult series of medulloblastomas of the posterior fossa did not demonstrate an improvement in progression free survival with gross total resection, although complete resection was associated with a decreased rate of local recurrence. 14) The extent of surgical resection may be influenced by many factors: goal of surgery (biopsy, debulking, complete resection), surgeon's skill and experience, tumor invasion and involvement with adjacent structures, and physician beliefs about the effectiveness of alternative therapies (irradiation therapy, chemotherapy). While our data indicate a survival benefit from complete resection, it is unclear whether the surgeon's goal for every adult case of pineoblastoma should be the complete resection of tumor. Incomplete functional status data did not allow a comprehensive assessment of the impact of complete resection on quality of life. It is conceivable that more aggressive surgery may even reduce quality of life, resulting in a Pyrrhic victory for the surgeon and patient.
IV. Radiotherapy
We found that cranial irradiation therapy doses of at least 40 Gy were associated with improved survival in adults with pineoblastomas. Patients who received AE40 Gy of cranial irradiation had a death rate 3.8 times less than that of patients who received less radiation. Median survival for the higher dose patients (29.8 months) was triple that of patients receiving lesser doses (8.1 months) (Fig. 3A) .
In the pediatric pineoblastoma population, the CCG-921 report suggests that radiation therapy has a significant impact on survival with a 3-year survival of 61%. 21) However, the early delayed toxicity of radiation therapy in the pediatric population was devastating -all patients º9 years of age suffered severe neurocognitive deficits. Craniospinal radiation was``somewhat effective'' as part of initial therapy in adults with pineoblastomas, but this study was not designed to evaluate the effects of radiation therapy. 4) Nevertheless, the findings in the pediatric populations have been extended to the adult population, and irradiation therapy is generally accepted as beneficial for adults with pineoblastomas. Our study supports this practice, and provides evidence for a threshold dose of À40 Gy for improved adult survival. A similar radiation dose threshold effect has been seen in children with PNETs. Several investigators have demonstrated that children with posterior fossa medulloblastomas treated with doses less than 50 Gy have poorer survival than those receiving greater than 50 Gy. 5, 8, 25, 34) Adults with medulloblastomas of the posterior fossa show a trend towards improved survival with higher radiation doses, but no statistically significant benefit.
V. Sex
This is the first pineoblastoma series to suggest a possible survival difference between males and females. The multivariate model showed only a trend towards improved survival in women (p ＝ 0.099), but the death rate in women was 3.0 times lower than that for men, and the difference in median survival was quite striking -20.0 months in men versus À107.5 months in women (Fig. 3C) . One other study of PNETs has shown a similar sex-related survival advantage. Male sex was correlated in the proportional hazards model with decreased survival (p ＝ 0.06) studied 47 adults with medulloblastomas. 29) The observed survival advantage of adult females with pineoblastomas may be caused by endocrinological differences between adult females and males. This novel preliminary finding suggests that further investigations focusing on sex-specific differences in biochemistry may prove fruitful. For example, assays of hormone receptors in banked tumor samples may provide useful information, ultimately leading to hormonal strategies in the treatment of adult PNETs, including adult pineoblastomas.
VI. Age
Age was not a statistically significant predictor of survival for adults AE16 years of age in our study. Nevertheless, children with pineoblastomas may have better outcomes than do adults. The 3-year progression-free survival was 61 ± 13% in a group of 17 children older than 18 months with pineoblastomas who were treated with craniospinal irradiation therapy and chemotherapy. 21) Thus, it appears that children (À18 months to 21 years of age) with pineoblastomas treated with irradiation therapy (AE45 Gy) and chemotherapy may fare better than do adults. Unfortunately, these two populations cannot be directly compared because of the many differences between the patient groups. The effect of age on survival may be better studied by analyzing a homogeneous group such as the BTRJ series of both adults and children.
VII. Staging
Medulloblastomas tend to metastasize through the CSF pathways, and the extent of disease dissemination through the craniospinal axis is accepted as an important prognostic factor. 14, 29) Similarly, the presence of disseminated disease in patients with pineoblastomas may be a significant predictor of survival. 4) In our series of 34 patients, six patients (17.6%) were categorized as having spinal dissemination. The details and extent of staging of individual patients were not recorded in the BTRJ, and it is unclear whether every patient underwent spinal imaging and CSF cytology. For comparison, five of 11 adults with pineoblastoma had spinal dissemina-Pineoblastoma Survival in Adults tion. 4) Although the lack of systematic criteria for determining the presence of metastasis or dissemination suggests that our observed incidence of 17.6% is low, the incidence varies considerably within the pediatric literature on PNETs. 10, 11, 20, 32) Given the presumed similarity of medulloblastomas and pineoblastomas, it is advisable to stage patients with both magnetic resonance imaging and CSF cytology prior to operative resection. If magnetic resonance imaging is not available, computed tomography myelography is an appropriate substitute. Although rare reports of metastases of pineoblastomas to extraneural sites exist, the frequency is so low that further studies are not warranted. 24, 30) Multivariate analysis did not find the presence of tumor dissemination to be a significant predictor of survival, but rigorous prospective staging protocols will be needed to determine the importance of staging in adults with pineoblastomas.
VIII. Functional status
Missing functional status data for 11 of the 34 patients precluded including this variable in the survival models. This is unfortunate, as functional status is a strong predictor of survival in many neurological diseases, e.g., ischemic stroke, 27) aneurysmal subarachnoid hemorrhage, 23) malignant gliomas, 36, 37) and brain metastases. 1, 16) Since functional status is also an important outcome measure, despite the limited number of patients with analyzable data, we searched for predictors of postoperative functional status in the subset of patients with preand postoperative PS data. Cranial irradiation therapy dose AE40 Gy was the only factor that improved postoperative functional status as measured by the PS grade. Functional status can be used as a proxy for quality of life. The beneficial effect of irradiation therapy on PS suggests that irradiation therapy may improve both the quality of life and duration of survival.
IX. Chemotherapy
The most controversial decision in the treatment of patients with PNETs is the role of chemotherapy. Considering the biologic similarity of medulloblastomas and pineoblastomas, the effectiveness of chemotherapeutic agents in medulloblastomas has suggested a parallel role of these agents in the treatment of patients with pineoblastomas. 12, 15, 26) Current agents used for PNETs include cyclophosphamide, cisplatin, carboplatin, vincristine, ifosmide, and etoposide. 2, 17) While our study did not show any impact of chemotherapy on survival, the power of our analysis was limited by the small number of patients who received chemotherapy (n ＝ 10, 29.4%) and the many different regimens used in these patients. Future studies should be directed towards the determination of the best chemotherapy regimen.
X. Limitations
This retrospective study of a national centralized registry study has several limitations. The analysis was limited to variables and coding methods contained in the dataset. Some patients had missing values in some data fields, e.g., PS measurement of functional status. Nevertheless, the BTRJ is a unique resource that provides useful data for the study of rare tumors such as pineoblastomas.
XI. Conclusion
Pineoblastomas in adults are rare. A retrospective study of 34 patients identified from 30 years of BTRJ data demonstrates an overall median survival of 25.7 months. Patients with gross total resection and cranial radiation AE40 Gy survive longer than do patients with subtotal resection or lower cranial radiation doses. Females had a trend towards longer survival than males. The role of chemotherapy remains unclear. Given the striking survival benefit of gross total surgical resection and higher radiation doses, the role of radiosurgery in the management of adult pineoblastomas remains to be assessed.
